Pages that link to "Q43581908"
The following pages link to Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in parkinson's disease (Q43581908):
Displaying 43 items.
- Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repair (Q21284516) (← links)
- Characterization of fetal antigen 1/delta-like 1 homologue expressing cells in the rat nigrostriatal system: effects of a unilateral 6-hydroxydopamine lesion (Q27318322) (← links)
- Parkinson's disease as a result of aging (Q28084395) (← links)
- Behavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits (Q30454614) (← links)
- Differential effects of intrastriatal 6-hydroxydopamine on cell number and morphology in midbrain dopaminergic subregions of the rat (Q30585312) (← links)
- Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection (Q31172552) (← links)
- An endogenous serine/threonine protein phosphatase inhibitor, G-substrate, reduces vulnerability in models of Parkinson's disease (Q33292773) (← links)
- Effects of low doses of intracerebroventricular 6-OHDA on the levels of monoaminergic neurotransmitters in rat brain structures (Q33805837) (← links)
- Selective neuronal vulnerability to oxidative stress in the brain (Q33868370) (← links)
- Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease (Q34032608) (← links)
- Endogenous repair by the activation of cell survival signalling cascades during the early stages of rat Parkinsonism (Q34516390) (← links)
- Activation of GSK-3β and caspase-3 occurs in Nigral dopamine neurons during the development of apoptosis activated by a striatal injection of 6-hydroxydopamine (Q34936413) (← links)
- An inflammatory review of Parkinson's disease. (Q35046915) (← links)
- What basal ganglia changes underlie the parkinsonian state? The significance of neuronal oscillatory activity (Q35053921) (← links)
- Oscillatory Activity in Basal Ganglia and Motor Cortex in an Awake Behaving Rodent Model of Parkinson's Disease (Q35056590) (← links)
- Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease (Q35125001) (← links)
- Functional diversity of ventral midbrain dopamine and GABAergic neurons (Q35794531) (← links)
- Inflammation as a causative factor in the aetiology of Parkinson's disease (Q36052641) (← links)
- A novel use of combined tyrosine hydroxylase and silver nucleolar staining to determine the effects of a unilateral intrastriatal 6-hydroxydopamine lesion in the substantia nigra: a stereological study (Q36236583) (← links)
- Transgenic reporter mice as tools for studies of transplantability and connectivity of dopamine neuron precursors in fetal tissue grafts (Q37574386) (← links)
- Phenotype, compartmental organization and differential vulnerability of nigral dopaminergic neurons. (Q37735797) (← links)
- Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease (Q37809751) (← links)
- Implications of cellular models of dopamine neurons for disease. (Q38943090) (← links)
- Calretinin Immunoreactivity in the Human Testis Throughout Fetal Life. (Q39090007) (← links)
- Differential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase. (Q39310243) (← links)
- Effect of 6-hydroxydopamine on striatal GDNF and nigral GFRα1 and RET mRNAs in the adult rat (Q40626282) (← links)
- Effect of Levodopa on Reward and Impulsivity in a Rat Model of Parkinson's Disease (Q41334077) (← links)
- Understanding and prevention of "therapy-" induced dyskinesias (Q42052125) (← links)
- Mesostriatal and mesolimbic projections of midbrain neurons immunoreactive for estrogen receptor beta or androgen receptors in rats (Q42465488) (← links)
- Dopamine depletion causes fragmented clustering of neurons in the sensorimotor striatum: evidence of lasting reorganization of corticostriatal input. (Q42525431) (← links)
- Striatal vessels receive phosphorylated tyrosine hydroxylase-rich innervation from midbrain dopaminergic neurons. (Q42839787) (← links)
- Specific oxidative stress profile associated with partial striatal dopaminergic depletion by 6-hydroxydopamine as assessed by a novel multifunctional marker molecule (Q43108497) (← links)
- Guidance of dopaminergic neuritic growth by immature astrocytes in organotypic cultures of rat fetal ventral mesencephalon (Q43864491) (← links)
- Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease (Q44054393) (← links)
- Extracellular taurine in the substantia nigra: taurine-glutamate interaction (Q44870581) (← links)
- Systemic administration of N-acetylcysteine protects dopaminergic neurons against 6-hydroxydopamine-induced degeneration. (Q44870592) (← links)
- Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons (Q45081906) (← links)
- Effects of anaesthetics on the loss of nigrostriatal dopaminergic neurons by 6-hydroxydopamine in rats (Q46636506) (← links)
- Calcium dynamics control K-ATP channel-mediated bursting in substantia nigra dopamine neurons: a combined experimental and modeling study (Q47661489) (← links)
- Striatal glutamate induces retrograde excitotoxicity and neuronal degeneration of intralaminar thalamic nuclei: their potential relevance for Parkinson's disease (Q48092207) (← links)
- Noise benefit in prepulse inhibition of the acoustic startle reflex. (Q51894922) (← links)
- Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI (Q89680587) (← links)
- Heterogeneous expression of dopaminergic markers and Vglut2 in mouse mesodiencephalic dopaminergic nuclei A8-A13 (Q99637823) (← links)